Related Experiment Video
Updated: Jan 24, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Emerging Interventional Pulmonary Therapies for Chronic Obstructive Pulmonary Disease
Alexander S Rabin1, Colleen M Keyes2, Catherine L Oberg2
1Division of Pulmonary, Critical Care, and Sleep Medicine, Tufts Medical Center.
Newer bronchoscopic lung volume reduction (bLVR) offers a promising treatment for chronic obstructive pulmonary disease (COPD). This review details bLVR imaging, benefits, and risks, guiding interdisciplinary care for COPD patients.
Area of Science:
- Pulmonology
- Interventional Pulmonology
- Radiology
Background:
- Chronic obstructive pulmonary disease (COPD) involves progressive airflow limitation due to airway and parenchymal inflammation.
- Current COPD therapies offer limited mortality benefits, with only oxygen and surgical lung volume reduction (LVRS) demonstrating survival advantages.
- Bronchoscopic lung volume reduction (bLVR) is an emerging interventional technique for COPD management.
Purpose of the Study:
- To review the latest interventional pulmonary techniques for COPD treatment, focusing on bLVR.
- To discuss pre- and post-procedure imaging evaluations for bLVR.
- To explore the potential benefits and risks of bLVR based on current clinical trial evidence.
Main Methods:
- Review of current literature on interventional pulmonary techniques for COPD.
- Emphasis on bronchoscopic lung volume reduction (bLVR) procedures.
- Analysis of imaging findings and clinical trial data related to bLVR.
Main Results:
- bLVR requires an interdisciplinary approach involving pulmonologists and radiologists.
- Imaging plays a crucial role in pre-procedure patient selection and post-procedure assessment.
- Clinical trial evidence is emerging regarding the benefits and risks of bLVR therapy.
Conclusions:
- bLVR represents a significant advancement in COPD treatment options.
- Careful patient selection and imaging are critical for successful bLVR outcomes.
- Further research and clinical trials are needed to fully establish the role of bLVR in COPD management.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

